A meta-analysis was performed to identify empirical data assessing the effects of a single nucleotide polymorphisms of sortilin-related receptor on Alzheimer's disease based on 14 studies involving 37941 cases and 49727 control studies. The results show an increased risk between the single nucleotide polymorphisms (rs641120, rs1010159) and Alzheimer's disease susceptibility in Asian populations, single nucleotide polymorphisms rs689021 was associated with a decreased risk in Caucasians, and single nucleotide polymorphisms rs641120 was detected as a decreased risk in both populations. Given these data, we provide crucial evidence to manifest that a significant relationship exists between SORL1 polymorphisms and the susceptibility of Alzheimer's disease.
BachurinS.O., BovinaE.V. and UstyugovA.A., Drugs in clinical trials for Alzheimer's disease: The major trends, Med. Res. Rev.37(5) (2017), 1186–1225. doi:10.1002/med.21434.
4.
VassarR., BennettB.D., Babu-KhanS., KahnS., MendiazE.A., DenisP., TeplowD.B., RossS., AmaranteP., LoeloffR., LuoY., FisherS., FullerJ., EdensonS., LileJ., JarosinskiM.A., BiereA.L., CurranE., BurgessT., LouisJ.C., CollinsF., TreanorJ., RogersG. and CitronM., Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science286(5440) (1999), 735–741. doi:10.1126/science.286.5440.735.
5.
GlennerG.G. and WongC.W., Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun.425(3) (2012), 534–539. doi:10.1016/j.bbrc.2012.08.020.
6.
NathalieP. and Jean-NoëlO., Processing of amyloid precursor protein and amyloid peptide neurotoxicity, Curr. Alzheimer Res.5(2) (2008), 92–99. doi:10.2174/156720508783954721.
7.
AshokB.S., AjithT.A. and SivanesanS., Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease. Clin. Exp. Pharmacol. Physiol.44(3) (2017), 327–334. doi:10.1111/1440-1681.12717.
8.
GuntupalliS., WidagdoJ. and AnggonoV., Amyloid-β-induced dysregulation of AMPA receptor trafficking, Neural Plast.2016 (2016), 3204519. doi:10.1155/2016/3204519.
9.
TönniesE. and TrushinaE., Oxidative stress, synaptic dysfunction, and Alzheimer's disease, J. Alzheimer's Dis.57(4) (2017), 1105–1121. doi:10.3233/JAD-161088.
10.
IreneL.G., PaulaG.E., FrancL. and IsidreF., Genetic and transcriptomic profiles of inflammation in neurodegenerative diseases: Alzheimer, Parkinson, Creutzfeldt–Jakob and tauopathies, Int. J. Mol. Sci.17(2) (2016), 206. doi:10.3390/ijms17020206.
11.
CousinE., MacéS., RocherC., DibC., MuzardG., HannequinD., PradierL., DeleuzeJ.F., GéninE. and CampionD., No replication of genetic association between candidate polymorphisms and Alzheimer's disease, Neurobiol. Aging32(8) (2011), 1443–1451. doi:10.1016/j.neurobiolaging.2009.09.004.
12.
NaJ.Y., SongK., LeeJ.W., KimS. and KwonJ., Sortilin-related receptor 1 interacts with amyloid precursor protein and is activated by 6-shogaol, leading to inhibition of the amyloidogenic pathway, Biochem. Biophys. Res. Commun.484(4) (2017), 890–895. doi:10.1016/j.bbrc.2017.02.029.
13.
PiscopoP., TostoG., BelliC., TalaricoG., GalimbertiD., GaspariniM., CanevelliM., PoleggiA., CrestiniA., AlbaniD., ForloniG., LuccaU., QuadriP., TettamantiM., FenoglioC., ScarpiniE., BrunoG., VanacoreN. and ConfaloniA., SORL1 gene is associated with the conversion from mild cognitive impairment to Alzheimer's disease, J. Alzheimer's Dis.46(3) (2015), 771–776. doi:10.3233/JAD-141551.
14.
MengY., LeeJ.H., ChengR., George-HyslopP.S., MayeuxR. and FarrerL.A., Association between SORL1 and Alzheimer's disease in a genome-wide study, Neuroreport18(17) (2007), 1761–1764. doi:10.1097/WNR.0b013e3282f13e7a.
15.
ZhangF., LiuX., WangB., ChengZ., ZhaoX., ZhuJ., WangD., WangY., DongA., LiP. and JinC., An exploratory study of the association between SORL1 polymorphisms and sporadic Alzheimer's disease in the Han Chinese population, Neuropsych. Dis. Treat.11 (2015), 1443–1448. doi:10.2147/NDT.S85370.
16.
OffeK., DodsonS.E., ShoemakerJ.T., FritzJ.J., GearingM., LeveyA.I. and LahJ.J., The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments, J. Neurosci.26(5) (2006), 1596–1603. doi:10.1523/JNEUROSCI.4946-05.2006.
KimuraR., YamamotoM., MoriharaT., AkatsuH., KudoT., KaminoK. and TakedM., SORL1 is genetically associated with Alzheimer disease in a Japanese population, Neurosci. Lett.461(2) (2009), 177–180. doi:10.1016/j.neulet.2009.06.014.
19.
FengX., HouD., DengY., LiW., TianM. and YuZ., SORL1 gene polymorphism association with late-onset Alzheimer's disease, Neurosci. Lett.584 (2015), 382–389. doi:10.1016/j.neulet.2014.10.055.
20.
ShibataN., OhnumaT., BabaH., HigashiS., NishiokaK. and AraiH., Genetic association between SORL1 polymorphisms and Alzheimer's disease in a Japanese population, Dement. Geriatr. Cogn. Disord.26(2) (2008), 161–164. doi:10.1159/000149821.
21.
NingM., YangY., ZhangZ., ChenZ., ZhaoT., ZhangD., ZhouD., XuJ., LiuZ., WangY., LiuY., ZhaoX., LiS. and HeL., Amyloid-β-related genes SORL1 and ACE are genetically associated with risk for late-onset Alzheimer disease in the Chinese population, Alzheimer Dis. Assoc. Disord.24(4) (2010), 390–396. doi:10.1097/WAD.0b013e3181e6a575.
22.
IzzoG., ForlenzaV.O., dos SantosB., BertolucciP.H.F., OjopiE.B., GattazW.F. and KerrD.S., Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: Interactions with the APOE genotype, Clinics68(2) (2013), 277–280. doi:10.6061/clinics/2013(02)RC01.
23.
WenY., MiyashitaA., KitamuraN., TsukieT., SaitoY., HatsutaH., MurayamaS., KakitaA., TakahashiH., AkatsuH., YamamotoT., KosakaK., YamaguchiH., AkazawaK., IharaY., KuwanR. and Japanese Alzheimer's Disease Neuroimaging Initiative, SORL1 is genetically associated with neuropathologically characterized late-onset Alzheimer's disease, J. Alzheimer's Dis.35(2) (2013), 387–394.
24.
MinsterR.L., DeKoskyS.T. and KambohM.I., No association of SORL1 SNPs with Alzheimer's disease, Neurosci. Lett.440(2) (2008), 190–192. doi:10.1016/j.neulet.2008.05.082.
25.
LeeJ.H., ChengR., SchupfN., ManlyJ., LantiguaR., SternY., TyckoB., RogaevaE., WakutaniY., FarrerL., George-HyslopP.S. and MayeuxR., The association between genetic variants in SORL1 and Alzheimer's disease in an urban, multiethnic, community-based cohort, Arch. Neurol.64(4) (2007), 501–506. doi:10.1001/archneur.64.4.501.
26.
ReynoldsC.A., HongM.G., ErikssonU.K., BlennowK., JohanssonB., MalmbergB., BergS., GatzM., PedersenL.N., AnnaM. and PrinceA.J., Sequence variation in SORL1 and dementia risk in Swedes, Neurogenetics11(1) (2010), 139–142. doi:10.1007/s10048-009-0210-4.
27.
LiY., RowlandC., CataneseJ., MorrisJ., LovestoneS., O'DonovanC.M., GoateA., OwenM., WilliamsJ. and GrupeA., SORL1 variants and risk of late-onset Alzheimer's disease, Neurobiol. Dis.29(2) (2008), 293–296. doi:10.1016/j.nbd.2007.09.001.
28.
LeeJ.H., ChengR., HonigL.S., VonsattelJ.-P.G., ClarkL. and MayeuxR., The association between genetic variants in SORL1 and autopsy-confirmed Alzheimer's disease, Neurology70(11) (2008), 887–889. doi:10.1212/01.wnl.0000280581.39755.89.
29.
CelliniE., TeddeA., BagnoliS., PradellaS., PiacentiniS., SorbiS. and NacmiasB., Implication of sex and SORL1 variants in Italian patients with Alzheimer disease, Arch. Neurol.66(10) (2009), 1260–1266. doi:10.1001/archneurol.2009.101.
30.
ChouC.-T., LiaoY.-C., LeeW.-J., WangS.-J. and FuhJ.-L., SORL1 gene, plasma biomarkers, and the risk of Alzheimer's disease for the Han Chinese population in Taiwan. Alzheimer's Res. Ther.8 (2016), 53. doi:10.1186/s13195-016-0222-x.
31.
CuccaroM.L., CarneyR.M., ZhangY., BohmC., KunkleB.W., VardarajanB.N., WhiteheadP.L., CukierH.N., MayeuxR., George-HyslopP.S. and Pericak-VanceM.A., SORL1 mutations in early- and late-onset Alzheimer disease, Neurol. Genet.2(6) (2016), e116. doi:10.1212/NXG.0000000000000116.
32.
DongH.K., GimJ.A., YeoS.H. and KimH.S., Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives, Gene597 (2017), 10–16. doi:10.1016/j.gene.2016.10.022.
33.
AndersenO.M., RudolphI.M. and WillnowT.E., Risk factor SORL1: From genetic association to functional validation in Alzheimer's disease, Acta Neuropathol.132(5) (2016), 653–665. doi:10.1007/s00401-016-1615-4.
34.
FernándezM.V., BlackK., CarrellD., SaefB., BuddeJ., DemingY., HowellsB., Del-AguilaJ.L., MaS., BiC., NortonJ., ChasseR., MorrisJ., GoateA., CruchagaC. and NIA-LOAD family study group, NCRAD, SORL1 variants across Alzheimer's disease European American cohorts, Eur. J. Hum. Genet.24(12) (2016), 1828–1830. doi:10.1038/ejhg.2016.122.
35.
SchmidtV., SchulzN., YanX., SchürmannA., KempaS., KernM., BlüherM., PoyM.N., OlivecronaG. and WillnowT.E., SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity, J. Clin. Invest.126(7) (2016), 2706–2720. doi:10.1172/JCI84708.
36.
WangZ., LeiH., ZhengM., LiY., CuiY. and HaoF., Meta-analysis of the association between Alzheimer disease and variants in GAB2, PICALM, and SORL1, Mol. Neurobiol.53(9) (2016), 6501–6510. doi:10.1007/s12035-015-9546-y.
37.
OlgiatiP., PolitisA., AlbaniD., RodilossiS., PolitoL., AteriE., ZisakiA., PiperiC., LiappasI., StamouliE., MailisA., AttiA.R., FerrariB., MoriniV., MorettiF., BiellaG., ForloniG., PapadimitriouG.N., De RonchiD., KalofoutisA. and SerrettiA., Association of SORL1 alleles with late-onset Alzheimer's disease. Findings from the GIGAS_LOAD study and mega-analysis, Curr. Alzheimer Res.9 (2012), 491–499. doi:10.2174/156720512800492431.
38.
JessicaE., Boulanger-WeillJ., WilliamsD., WoodruffG., BuenF., RevillaA., HerreraC., IsraelM., YuanS., EdlandS. and GoldsteinL., Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells, Cell Stem Cell16(4) (2015), 373–385. doi:10.1016/j.stem.2015.02.004.
39.
LiuF., IkramM.A., JanssensA.C., SchuurM., de KoningI., IsaacsA., StruchalinM., UitterlindenA.G., den DunnenJ.T., SleegersK., BettensK., Van BroeckhovenC., van SwietenJ., HofmanA., OostraB.A., AulchenkoY.S., BretelerM.M. and van DuijnC.M., A study of the SORL1 gene in Alzheimer's disease and cognitive function, J. Alzheimer's Dis.18(1) (2009), 51–64. doi:10.3233/JAD-2009-1137.
